The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Any low volume of daily trades allows B of A to marshall the market but the bottom line is that they are accumulating
Bank of America now increased to 7.8%. Sold to reduce price per share and then buy at a cheaper rate. They ain’t going away
Proleukin should be depreciated…surprised a write down was not taken this year.
Like the services business…limited capital required, easy to scale and they keep signing new contracts….would be good to know the fees by contract to see f they are signing big deals.
BOA has reduced its holding this week 8.3% down to 6.8%…..no deal emerging..
I’m expecting Proleukin to be a write off at some point. Sooner the better - get it out of the way I reckon.
Services side of the business is a different game altogether. Generates revenue that supports a dividend for investors( I’d happily forgo a dividend if the focus was on reducing debt). Clinigen has a niche product with still massive potential for growth.
At the rate Bank of America are increasing their stake in the business, Can’t be long before a bid
Bank of America still accumulating. The wolves are crouched in the bushes. Just hope it’s a costly pounce.
COVID drug treatment offers more hope……….and Elliot plotting in the background too
A big fat zero so far.
Goolang,have you lost the plot ?
Paying good money to acquire failing products in the hope of revitalising them is not a strong business model…..however trying to offload the products division at a time of depressed demand is not easy and is unlikely to get a decent price.
May be professionals Buying while some weak holders,
mainly PI's sell.
Someone knows something here ....12% fall yesterday now recovered most of that
“Profit warning hits shares in Pharma Services Company”. Article in Business Section. Reference to Elliott exploring future options. Also reference to a competitor having leapfrogged Erwinase to capture US market.
P.O.S
I think it’s safe to say that the market was not entirely happy with the financials. I’m staying with it but CEO needs to look over his shoulder. Elliott will have him in their sights. We all want a fair return on our investments - but the big players don’t just want, they demand.
I would expect an RNS within 2 days regarding the wild trading towards the close today. Could not get a quote and buy order was repeatedly rejected. Long term this should pay in spaded. IC positive today. Cheap at 11 p.e.
I thankfully sold out last Friday due to the Elliot news and just cancelled my buy order for 600p. Takeover speculation is the only reason to have a punt on this at the moment.
I’m still pretty positive, not in the underperforming management, but that Elliott Investment Management will fire a rocket under the company and get the share price moving with it…patience required, this is not the usual Aim pump and dump tripe
This is why AIM is bad.
Cant see anything in results that was not in the trading statement. Drop represents buy opportunity IMHO
months to scrape back some of the £2.50 drop from early summer, and then the results come out from what thinks itself as a big company and worth big share price and boom, behaves like a penny share, what a piece of crap
We will have to see what Elliot thinks should happen…..maybe a sale of one of the divisions?
I would rather they were service and distributors for others products than product owners (much more stable). They have announced a series of new deals in the last few months.
Expect some turbulence.
Do they want to sell one of the two divisions?
They usually write a letter to the chairman stating how they think value can be realised.
Not if it’s a precursor to a take over
Looks like Elliott International have bought 5+% of stock which is the probable cause for the recent resilience over the last few days